Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study.
Ali, Ziad A; Karimi Galougahi, Keyvan; Nazif, Tamim; Maehara, Akiko; Hardy, Mark A; Cohen, David J; Ratner, Lloyd E; Collins, Michael B; Moses, Jeffrey W; Kirtane, Ajay J; Stone, Gregg W; Karmpaliotis, Dimitri; Leon, Martin B.
Eur Heart J
; 37(40): 3090-3095, 2016 10 21.
Artigo em Inglês | MEDLINE | ID: mdl-26957421
Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
[Safety of percutaneous coronary intervention in patients with acute coronary syndromes complicating chronic kidney disease].
[Clinical characteristics among CABG or PCI which to treat chronic kidney disease with unprotected left main coronary artery disease].
Coronary revascularization in chronic kidney disease patients, external validity of meta-analysis results.
CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?
Fórmula de CKDEPI versus CockcroftGault na predição de nefropatia induzida por contraste após intervenção coronária percutânea, em pacientes sem disfunção renal significativa.
Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis.
Hyperuricemia is an independent risk factor for mortality only if chronic kidney disease is present.
[The relationship between hyperuricemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention].
[The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction].